Neda Haghighi

Dr Neda Haghighi

MD, FRANZCR
Radiation Oncologist
Become a Patient

Biography

Dr Neda Haghighi is an experienced radiation oncologist at Icon Cancer Centre Richmond and Icon Cancer Centre Holmesglen. She has superior knowledge in the management and treatment of brain and spinal tumours and has completed an extended fellowship in intracranial and extracranial stereotactic radiation therapy.

Dr Haghighi maintains a strong interest in clinical research relating to stereotactic treatment of CNS conditions and oligometastatic disease. She is the primary investigator; co-investigator and trial management committee member of several clinical trials in the field of CNS-related malignancies at Icon Cancer Centre and Peter MacCallum Cancer Centre.

She is an active member of  Trans Tasmanian Radiation Oncology Group (TROG), Cooperative Trials Group for Neuro-Oncology (COGNO) and International Society of Radiosurgery (ISRS) and is a committee member on several CNS-related interest groups. She has a special interest in radiosurgery for the treatment of benign base of skull conditions as well as functional neurological disorders. Dr Haghighi has published journal articles relating to stereotactic radiotherapy and has been an invited speaker at conferences and meetings relating to intracranial conditions and radiosurgery. She has written several of the departmental protocols relating to stereotactic radiation therapy treatment of benign and malignant conditions.

Affiliations & Memberships

  • Royal Australian and New Zealand College of Radiologists (RANZCR)
  • International Stereotactic Radiosurgery Society (ISRS)
  • Trans Tasman Radiation Oncology Group (TROG)
  • Cooperative Trials Group for Neuro-Oncology (COGNO)

Special Interests

Dr Neda Haghighi accepts referrals for all cancer types, with a special clinical interest in:
  • Brain and spinal (CNS) cancer
  • Oligometastatic disease
  • Stereotactic radiation therapy

Icon Locations

Epworth Richmond View centre
Holmesglen View centre

Visiting Locations

  • Peter MacCallum Cancer Centre